Ligand Pharmaceuticals reported $432.08M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acceleron Pharma XLRN:US $ 696.61M 21.16M
Amgen AMGN:US $ 24380M 5281M
Anika Therapeutics ANIK:US $ 165.78M 11.98M
Arena Pharmaceuticals ARNA:US $ 790.92M 199.52M
Arrowhead Research ARWR:US $ 384.6M 141.36M
Baxter International BAX:US $ 8167M 163M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Clovis Oncology CLVS:US $ 230.67M 65.69M
Dicerna Pharmaceuticals DRNA:US $ 589M 27.49M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Enanta Pharmaceuticals ENTA:US $ 319.02M 2.13M
Endo International Ordinary Shares ENDP:US $ 2748.95M 179.62M
Flexion Therapeutics FLXN:US $ 192.76M 8.64M
Gilead Sciences GILD:US $ 14200M 275M
Glaxosmithkline GSK:US $ 18254M 688M
GlaxoSmithKline GSK:LN 18.25B 688M
Harsco HSC:US $ 887.58M 26.23M
Heron Therapeutics HRTX:US $ 315.05M 51.77M
Immunogen IMGN:US $ 296.8M 22.41M
Insmed INSM:US $ 958.98M 79.21M
Intrexon XON:US $ 153.09M 3.59M
IONIS PHARMACEUT IONS:US $ 2156M 82.42M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Lannett LCI:US $ 364.89M 11.33M
Ligand Pharmaceuticals LGND:US $ 432.08M 21.18M
Macrogenics MGNX:US $ 334.7M 32.3M
Pacira Pharmaceuticals PCRX:US $ 822.35M 29.77M
Rigel Pharmaceuticals RIGL:US $ 171.1M 13.09M
Sangamo Biosciences SGMO:US $ 447.4M 106.67M
Spectrum Pharmaceuticals SPPI:US $ 140M 25.71M
Teva Pharmaceutical Industries TEVA:US $ 12154M 668M
Veracyte VCYT:US $ 229.31M 142.04M